BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33530404)

  • 21. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
    Faria M; de Pinho MN
    Transl Res; 2021 Mar; 229():115-134. PubMed ID: 32891787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphate, Microbiota and CKD.
    Favero C; Carriazo S; Cuarental L; Fernandez-Prado R; Gomá-Garcés E; Perez-Gomez MV; Ortiz A; Fernandez-Fernandez B; Sanchez-Niño MD
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease.
    Cupisti A; Piccoli GB; Gallieni M
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):71-79. PubMed ID: 31725009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease.
    Wu CL; Tarng DC
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
    Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
    Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uremic toxins and gut micro biome].
    Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
    Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
    Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.
    Addi T; Dou L; Burtey S
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
    Kikuchi M; Ueno M; Itoh Y; Suda W; Hattori M
    Nephron; 2017; 135(1):51-60. PubMed ID: 27701177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pleiotropic effects of sevelamer: a model of intestinal tract chelating agent].
    Massy ZA; Maizel J
    Nephrol Ther; 2014 Nov; 10(6):441-50. PubMed ID: 25070605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.
    Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Nutrients; 2017 May; 9(5):. PubMed ID: 28498348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CharXgen-Activated Bamboo Charcoal Encapsulated in Sodium Alginate Microsphere as the Absorbent of Uremic Toxins to Retard Kidney Function Deterioration.
    Lin CJ; Sun CY; Wu CJ; Wu CC; Wu V; Lin FH
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding and Therapeutic Strategies of Chinese Medicine on Gut-Derived Uremic Toxins in Chronic Kidney Disease.
    Guo C; Rao XR
    Chin J Integr Med; 2018 Jun; 24(6):403-405. PubMed ID: 29752692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
    Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.